APA

Witzel I., Loibl S., von Minckwitz G., Mundhenke C., Huober J., Hanusch C., Henschen S., Hauschild M., Lantzsch T., Tesch H., Latos K., Just M., Hilfrich J., Barinoff J., Eulenburg C. Z., Roller M., Untch M. & Müller V. (20101208). Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. : Breast cancer research and treatment.

Chicago

Witzel Isabell, Loibl Sibylle, von Minckwitz Gunter, Mundhenke Christoph, Huober Jens, Hanusch Claus, Henschen Stephan, Hauschild Maik, Lantzsch Tilmann, Tesch Hans, Latos Kunibert, Just Marianne, Hilfrich Jörn, Barinoff Jana, Eulenburg Christine Zu, Roller Marc, Untch Michael and Müller Volkmar. 20101208. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. : Breast cancer research and treatment.

Harvard

Witzel I., Loibl S., von Minckwitz G., Mundhenke C., Huober J., Hanusch C., Henschen S., Hauschild M., Lantzsch T., Tesch H., Latos K., Just M., Hilfrich J., Barinoff J., Eulenburg C. Z., Roller M., Untch M. and Müller V. (20101208). Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. : Breast cancer research and treatment.

MLA

Witzel Isabell, Loibl Sibylle, von Minckwitz Gunter, Mundhenke Christoph, Huober Jens, Hanusch Claus, Henschen Stephan, Hauschild Maik, Lantzsch Tilmann, Tesch Hans, Latos Kunibert, Just Marianne, Hilfrich Jörn, Barinoff Jana, Eulenburg Christine Zu, Roller Marc, Untch Michael and Müller Volkmar. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. : Breast cancer research and treatment. 20101208.